References
- Epstein BJ, Vogel K, Palmer BF. Dihydropyridine calcium channel antagonists in the management of hypertension. Drugs. 2007;67:1309–1327.
- Fares H, DiNicolantonio JJ, O’Keefe JH, et al. Amlodipine in hypertension: a first-line agent with efficacy for improving blood pressure and patient outcomes. Open Hear. 2016;3:1–7.
- Bradea O, Kacso I, Borodi G, et al. Complexation of amlodipine besylate with β-cyclodextrin. Acta Chim Slov. 2012;59:18–23.
- Di Trani N, Liu HC, Qi R, et al. Long-acting tunable release of amlodipine loaded PEG-PCL micelles for tailored treatment of chronic hypertension. Nanomed Nanotechnol Biol Med. 2021;37:102417.
- Berkels R, Taubert D, Bartels H, et al. Amlodipine increases endothelial nitric oxide by dual mechanisms. Pharmacology. 2004;70:39–45.
- Somagoni J, Reddy S, Katakam VK. Preparation of inclusion complexes of amlodipine base and its besylate and maleate salts with hydroxy propyl b -cyclodextrin -A study on stereospecific dissolution. Pharm Anal Acta. 2011;02:1000123.
- Jouyban A. Handbook of Solubility Data for Pharmaceuticals. 1st ed Boca Raton: CRC Press; 2010.
- Barzegar-Jalali M, Shayanfar A, Yaqoubi S, et al. Combination of the double log–log model with Abraham solvation parameters to predict solubility of drugs in ethanol + water mixtures. J Solution Chem. 2016;45:1425–1433.
- Rahimpour E, Acree Jr WE, Jouyban A. Prediction of sulfonamides’ solubilities in the mixed solvents using solvation parameters. J Mol Liq. 2021;339:116269.
- Sardari F, Jouyban A. Solubility of 3-Ethyl-5-methyl-(4 RS)-2-((2-aminoethoxy)methyl)-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate monobenzenesulfonate (amlodipine besylate) in ethanol + water and propane-1,2-diol + water mixtures at various temperatures. J Chem Eng Data. 2012;57:2848–2854.
- Behboudi E, Soleymani J, Martinez F, et al. Solubility of amlodipine besylate in binary mixtures of polyethylene glycol 400 + water at various temperatures: Measurement and modelling. J Mol Liq. 2022;347:118394.
- Ayorinde JO, Odeniyi MA, Balogun-Agbaje O. Formulation and evaluation of oral dissolving films of amlodipine besylate using blends of starches with hydroxypropyl methyl cellulose. Polim Med. 2016;46:45–51.
- Pezik E, Gulsun T, Sahin S, et al. Development and characterization of pullulan-based orally disintegrating films containing amlodipine besylate. Eur J Pharm Sci. 2021;156:105597.
- Pawar K, Render D, Rangari V, et al. Evaluation of non-crystalline cellulose as a novel excipient in solid dose products. Drug Dev Ind Pharm. 2018;44:1512–1519.
- Hariharan G, Sudhakar M, Vinay R. Development and optimization of bilayer hydrodyanamically balanced system of Amlodipine Besylate immediate release and Hydrochlorothiazide controlled release. Asian J Pharm Clin Res. 2013;6:243–246.
- Williams HD, Ford L, Lim S, et al. Transformation of biopharmaceutical classification system class i and iii drugs into ionic liquids and lipophilic salts for enhanced developability using lipid formulations. J Pharm Sci. 2018;107:203–216.
- Thakur Y, Maheshwari RK. Novel application of mixed solvency concept to develop and formulate dry powder injection for reconstitution of a poorly water soluble drug, amlodipine besylate and their evaluations. J Drug Deliv Ther. 2021;11:101–108.
- Shaikh SA, Shaikh SS, Shahi SR, et al. Formulation and evaluation of s-(-)-amlodipine besylate and nebivolol hydrochloride tablets. J Adv Pharm Technol Res. 2010;1:199–206.
- Kapor A, Nikolić V, Nikolić L, et al. Inclusion complexes of amlodipine besylate and cyclodextrins. Cent Eur J Chem. 2010;8:834–841.
- Lauro MR, Carbone C, Auditore R, et al. A new inclusion complex of amlodipine besylate and soluble β-cyclodextrin polymer: Preparation, characterization and dissolution profile. J Incl Phenom Macrocycl Chem. 2013;76:19–28.
- Garg S, Pathak K, Philip A, et al. Osmotically regulated two-compartment asymmetric membrane capsules for simultaneous controlled release of anti-hypertensive drugs. Sci Pharm. 2012;80:229–250.
- Jouyban A, Fakhree MAA. Experimental and computational methods pertaining to drug solubility. In: Acree Jr B, editor. Toxic Drug Test, New York, Intech open; 2012. p. 261–296.
- Grant DJW, Mehdizadeh M, Chow AL, et al. Non-linear van't Hoff solubility-temperature plots and their pharmaceutical interpretation. Int. J. Pharm. 1984;18:25–38.
- Acree Jr WE. Mathematical representation of thermodynamic properties. Part 2. Derivation of the combined nearly ideal binary solvent (NIBS)/Redlich-Kister mathematical representation from a two-body and three-body interactional mixing model. Thermochim Acta. 1992;198:71–79.
- Jouyban A, Acree Jr WE. Mathematical derivation of the Jouyban-Acree model to represent solute solubility data in mixed solvents at various temperatures. J Mol Liq. 2018;256:541–547.
- Ochsner AB, Belloto RJ, Sokoloski TD. Prediction of xanthine solubilities using statistical techniques. J Pharm Sci. 1985;74:132–135.
- Buchowski H, Ksiazczak A, Pietrzyk S. Solvent activity along a saturation line and solubility of hydrogen-bonding solids. J Phys Chem. 1980;84:975–979.
- Buchowski H, Khiat A. Solubility of solids in liquids: one-parameter solubility equation. Fluid Phase Equilib. 1986;25:273–278.
- Jouyban A. The modified Wilson model and predicting drug solubility in water-cosolvent mixtures. Chem Pharm Bull. 1998;46:1058–1061.
- Vahdati S, Shayanfar A, Hanaee J, et al. Solubility of carvedilol in ethanol + propylene glycol mixtures at various temperatures. Ind Eng Chem Res. 2013;52:16630–16636.
- Perlovich GL, Kurkov SV, Bauer-Brandl A. Thermodynamics of solutions: II. Flurbiprofen and diflunisal as models for studying solvation of drug substances. Eur J Pharm Sci. 2003;19:423–432.